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The Drosophila immune deficiency (IMD) signaling cascade regulates the IKK/NF-kB signaling cassette and
shares striking similarities with the mammalian TNF-R1 pathway. Thevenon et al. (2009) reveal how dUSP36,
a deubiquitinating enzyme of the ubiquitin-specific protease (USP) family, prevents the constitutive activation
of the IMD pathway by resident gut bacteria.The Drosophila genome encodes three
transcription factors of the nuclear factor-
kappa B (NF-kB) family: Dorsal, Dif, and
Relish, which regulate the expression of
hundreds of stress and immune response
genes, including those encoding antimi-
crobial peptides. They do so upon recog-
nition of bacteria by pattern-recognition
receptors of the peptidoglycan-recogni-
tion protein (PGRP) family, which trigger
the Toll and IMD signaling pathways to
activate Dif and Dorsal or Relish, respec-
tively. The Toll and IMD pathways share
striking similarities with the mammalian
IL-1-R/TLR and TNF-R1 intracellular sig-
naling cascades and represent useful
paradigms to study the regulation of NF-
kB-dependent innate immune signaling
in an in vivo setting (Ferrandon et al.,
2007). The IMD signaling cascade
involves the scaffold protein IMD, which
shares structural homologies with the
mammalian protein RIP1. Upon recruit-
ment to PGRP-LC, IMD triggers the acti-
vation of a signaling cassette involving
the TAB2/TAK1 and IKK complexes via
the adaptor dFADD and the Caspase-8
homolog Dredd. IKK then promotes
Relish phosphorylation and its nuclear
translocation. In parallel, TAB2/TAK1 also
activates the JNK cascade (Figure 1).
Over the last 15 years, genetic studies294 Cell Host & Microbe 6, October 22, 2009have revealed the central role of the IMD
signaling cascade in the activation of pro-
tective immune responses to septicemia
caused by Gram-negative bacteria (Fer-
randon et al., 2007). More recently, this
cascade has been implicated in the con-
trol of gut immune responses and resident
microbiota-gut mutualism (Ryu et al.,
2006, 2008). In the gut, IMD signaling
activity is fine-tuned by a subtle balance
of positive and negative inputs to promote
immune tolerance to beneficial resident
bacteria while responding robustly to
infection (Lhocine et al., 2008; Zaidman-
Re´my et al., 2006). A few years ago, ubiq-
uitination was reported to be involved
in the activation of IMD signaling (Zhou
et al., 2005). However, the targeted pro-
teins and most of the enzymes respon-
sible for these modifications remained
elusive. In this issue of Cell Host &
Microbe, Thevenon and colleagues now
reveal that modification of the scaffold
protein IMD with K63-linked polyubiquitin
chains is a critical step in the activity of
the signaling cascade (Thevenon et al.,
2009). Moreover, they demonstrate that
dUSP36, a deubiquitinating enzyme (DUB)
of the ubiquitin-specific protease (USP)
family, is an important regulator of this
process, antagonizing the constitutive
IMD signaling that would otherwise beª2009 Elsevier Inc.activated by gut-resident bacteria (Fig-
ure 1).
Thevenon et al. (2009) identified
dUSP36, the Drosophila ortholog of
human USP36, in an overexpression
screen aimed at identifying regulators of
host resistance to infection by Pseudo-
monas aeruginosa. Ubiquitous overex-
pression of dUSP36 enhances the
susceptibility of flies to P. aeruginosa
septicemia by antagonizing IMD signaling
activity. The effect of dUSP36 overex-
pression on IMD signaling relies entirely
on its ubiquitin protease activity, since
the expression of a catalytically dead
mutant version of dUSP36 affects neither
IMD signaling transcriptional outputs nor
flies’ resistance to P. aeruginosa septi-
cemia. Next, the authors generated a
loss-of-function mutation of dUSP36.
Such mutation causes an early lethality,
most probably associated with other roles
of dUSP36 in stem cell maintenance
and the regulation of developmental
apoptosis (Buszczak et al., 2009; Ribaya
et al., 2009). The authors elegantly
rescued this lethality by conditional
expression of a wild-type dUSP36 trans-
gene during development to study the
role of dUSP36 at the adult stage. In
parallel, they also used an in vivo-induc-
ible RNAi approach to selectively silence
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Figure 1. The Regulation of IMD Ubiquitination Status by dUSP36 Impacts on IMD Signaling Activity
Upon recognition of resident bacteria by PGRP-LC, the scaffold protein IMD is modified with K63-linked polyubiquitin chains to promote TAB2/TAK1 complex
activation, leading to IKK and JNK stimulation by yet-unknown mechanisms. In this issue of Cell Host & Microbe, Thevenon et al. (2009) reveal how dUSP36 influ-
ences the balance of IMD modification by K63- or K48-linked polyubiquitin chains: dUSP36-mediated removal of activating K63-linked polyubiquitin chains indi-
rectly promotes the addition of degradative K48-linked polyubiquitin chains. This buffering system antagonizes the constitutive activation of the IMD signaling
cascade by gut-resident bacteria to promote immune tolerance.dUSP36 expression in adult flies. Under
both conditions, the authors observed
a marked increase in the basal expression
of both IKK/Relish and JNK transcrip-
tional outputs in immune-competent
tissues (i.e., the intestinal epithelium and
the fat body, a functional equivalent of
the mammalian liver) compared to wild-
type flies. What causes the constitutive
IMD signaling observed to be associated
with the dUSP36 mutant then becomes
an important question.
Two hypotheses could be made to
explain these results. First, the observed
constitutive IMD signaling may be pro-
moted by resident bacteria, as already
observed for other negative regulators
of this signaling cascade (Lhocine et al.,
2008; Ryu et al., 2008). Alternatively,
the constitutive signaling observed in
dUSP36 mutant flies could merely result
from a mechanism-based constitutive
activation of the cascade independent ofany bacterial input. The authors ad-
dressed this point by raising the dUSP36
mutant flies in germ-free conditions in
order to eliminate resident bacteria. They
show that the constitutive activation of
IMD signaling in the gut epithelium
of dUSP36 mutant flies raised in con-
ventional conditions is lost under germ-
free conditions. This demonstrates that
dUSP36 antagonizes the constant activa-
tion of the IMD signaling cascade trig-
gered by the indigenous microbiota.
Therefore, dUSP36 contributes to the
establishment of the immune tolerance
that the Drosophila gut epithelium
develops toward its resident bacteria. An
important question now remaining is
whether this buffering system is flexible
or fixed. In others words, is this system
by itself able to balance the host response
to the bacterial content of the gut lumen,
or does it merely constitutively impose
a brake on IMD signaling in order to avoidCell Host & Microbe 6excessive basal activity? This is certainly
an issue to address in the future.
In addition, Thevenon et al. (2009)
analyzed dUSP36 molecular activity in
the IMD pathway. They first revealed,
using genetic epistasic analysis, that
dUSP36 functions at the level of the
scaffold protein IMD, downstream of the
pattern-recognition receptor PGRP-LC.
This result was corroborated by in vitro
GST pull-down and in vivo coimmunopre-
cipitation assays, which revealed a
direct interaction between the C-ter-
minal part of dUSP36 and the N-terminal
part of IMD. The author then made
the decisive observation that, in vivo and
in cultured cells, IMD is modified with
K63-linked polyubiquitin chains. After
showing that dUSP36 is indeed a USP,
given that its catalytic domain hydrolyzes
a ubiquitin-b-galactosidase substrate
when expressed in bacteria and digests
polyubiquitin-isopeptide bound in vitro,, October 22, 2009 ª2009 Elsevier Inc. 295
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modification and realized that in vivo
expression of dUSP36, but not its catalyt-
ically inactive mutant form, reduces the
amount of K63-linked polyubiquitin chains
on IMD and leads to increased degrada-
tion of IMD. In this setting, blocking the
proteasome restored a normal amount of
IMD, which then carried K48-linked polyu-
biquitin chains instead of K63-linked
polyubiquitin chains. Using these data,
the authors propose a model whereby
dUSP36 removes activating K63-polyubi-
quitin chains, added on IMD upon activa-
tion of the pathway by resident bacteria,
to indirectly promote IMD degradation by
the proteasome and antagonize IMD
signaling activity (Figure 1). This work rai-
ses several questions that will need to be
answered to fully comprehend how the
IMD signaling pathway is regulated by
ubiquitination. In particular, how and
where IMD is modified with K63-linked
polyubiquitin chains and how IMD modi-
fication triggers downstream signaling
events are important issues to address.
Previous reports have implicated two E2
ubiquitin-conjugating enzymes, Uev1a
and Ubc13, as well as the E3 ubiquitin
ligase DIAP2 as positive regulators of the
cascade acting upstream of TAK1 (Leulier
et al., 2006; Zhou et al., 2005). These mole-
cules, therefore, represent prime candi-
dates to control IMD ubiquitination status.296 Cell Host & Microbe 6, October 22, 200Taken together, these results obtained
in an in vivo setting shed light on the
important contribution of nondegradative
polyubiquitination in the regulation of
NF-kB signaling. In addition, they demon-
strate the key role of the USP dUSP36 in
the negative regulation of this process,
mediating immune tolerance to resident
gut bacteria. In mammals, multiple immu-
noregulatory DUBs have been reported
over the last few years. Indeed, CylD,
A20, and CEZANNE are involved in the
removal of K63-linked ubiquitin chains
on RIP1 during TNF-R1 signaling (Sun,
2008). However, the complexity of this
signaling cascade and the high level of
redundancy and pleiotropy associated
with these factors have hampered the
emergence of a clear understanding of
how DUBs fine-tune TNF-mediated
NF-kB signaling in vivo. Using Drosophila
genetics, Thevenon et al. (2009) now
unambiguously add dUSP36 to the
NF-kB map. Given the striking similarities
between the IMD and TNF-R1 signaling
cascades, it is now worth testing
hUSP36 function in TNF-mediated NF-kB
activation.
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